Dinesh V. Ph D. Patel, President and CEO at Protagonist Therapeutics, Inc (PTGX), sold 10,718 shares at $38.18 ($409K) on 2025-02-19, disclosed to the SEC on 2025-02-20.
Open-market sale of $409k PTGX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.18 | 5,359 | $205K | 50.0% |
| 2 | $38.18 | 5,359 | $205K | 50.0% |
| Total | $38.18 avg | 10,718 | $409K | 100% |
| Filing → |
| PTGX | SELL | 2026-03-25 | $5.5M | — | Filing → |
| PTGX | SELL | 2026-01-27 | $4.1M | — | Filing → |
| PTGX | SELL | 2026-01-21 | $2.8M | — | Filing → |